TrialJournal of Korean medical science2018

Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation.

Se-Hyuk Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.